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Intrathymic development can be divided into 
discrete stages at which thymocytes express 
distinct surface markers that include CD4, 8, 
25, and 44. Cells that express neither CD4 
nor CD8 are called double-negative (DN) 
cells that consist of CD25−CD44+ (DN1), 
CD25+CD44+ (DN2), CD25+CD44− (DN3), 
and CD25−CD44− (DN4) subsets (1). Thymus 
development is also characterized by sequential 
rearrangement and expression of TCR genes 
(2). Rearrangement of variable γ and δTCR 
gene segments begins at the DN2 stage and, if 
productive, results in CD4−CD8− (DN) cells 
that express γδTCR on the cell surface. Re-
arrangement of variable TCRβ gene segments 
sets in slightly later and, also if productive, re-
sults in the surface expression of the pre-TCR 
consisting of a TCRβ chain that is covalently 
associated with the pre-TCRα chain and non-
covalently associated with CD3 signal-trans-
ducing molecules (3, 4). The pre-TCR is 
expressed at rather low levels on DN3 and DN4 
cells (5). Pre-TCR–expressing DN cells un-
dergo several rounds of division before the re-
arrangement of variable TCRα gene segments 
sets in at the late DN4 and early CD4+CD8+ 
double-positive (DP) stage. This results in the 
surface expression of αβTCRs at the expense 
of the pre-TCR because TCRα chains gen-
erally compete favorably with pre-TCRα for 
TCRβ chains. TCRαβ-expressing DP cells 
then undergo positive or negative selection by 
intrathymic peptide–MHC complexes (6).
The temporal order of TCR V gene seg-
ment rearrangement has suggested the following 
scenario: DN4 cells that contain productive Tcrg 
and Tcrd rearrangements express γδTCR on the 
cell surface and, thereby, become functionally 
mature T cells that are ready to leave the thy-
mus. Pre-TCR–expressing cells will eventually 
become DP thymocytes expressing an αβTCR, 
the specifi  city of which determines their further 
developmental fate. This simple scheme of T cell 
development was found not to be valid when T 
cell development was analyzed in Ptcra-defi  cient 
mice. In contrast to CD3ε-defi  cient and Tcrb plus 
Tcrd double-defi  cient mice that contain none or 
very few DP thymocytes, Ptcra-defi  cient  mice 
were shown to harbor strongly reduced but still 
considerable numbers of DP thymocytes (7). Fur-
ther analysis in Ptcra,Tcrd as well as Ptcra,Tcra dou-
ble-defi  cient mice then revealed that both an early 
expressed γδTCR as well as an early expressed 
αβTCR could still rescue the development of 
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DP thymocytes in the absence of pre-TCR (8). In the case of 
αβTCR in Ptcra−/−,Tcrd−/− mice, this resulted in thymocytes 
of which >95% harbored TCRβ chains (i.e., DP cells that were 
selected by an early expressed αβTCR and therefore contained 
in-frame Tcrb rearrangements). In the case of an early expressed 
γδTCR in Ptcra−/−,Tcra−/− mice, only 15% of DP cells con-
tained TCRβ chains. Thus, these experiments indicated that 
receptors other than the pre-TCR could relieve DN3 cells from 
a development block resulting in the production of DP cells and 
that there must be a rearrangement of TCRα V gene segments 
at the DN3 or earlier stages of T cell development.
The temporal order of TCR V gene segment rearrange-
ment appears especially important with regard to the Tcra and 
Tcrd locus. This is where the Tcra locus is embedded in the Tcra 
locus and where the early rearrangement of Vδ gene segments 
results in the formation of TCRδ chains, whereas late Vα re-
arrangement is accompanied by the deletion of the Tcrd locus 
and generation of Tcra genes (9). Two diff  erent enhancer ele-
ments have been invoked in the control of rearrangement and 
expression of the Tcra/Tcrd locus: the Eδ enhancer located in 
the Jδ-Cδ intron and the Eα enhancer 4 kb downstream of Cα 
(10–13). Both enhancers have been deleted by homologous 
recombination. In Eδ−/− animals, the development of αβ T 
cells appeared to proceed normally with the exception that 
there was a considerable reduction of thymic and peripheral γδ 
T cells. In this context, Eδ-defi  cient alleles exhibited a substan-
tial reduction of Tcrd gene rearrangements. Eα−/− mice con-
tained normal numbers of DP cells but reduced numbers of 
CD4+CD8− and CD4−CD8+ single-positive (SP) cells as a 
result of an almost complete block in Vα to Jα rearrangements. 
The Eα enhancer also controls levels of αβ as well as γδTCR 
expression, as evident by reduced levels of TCRα and TCRδ 
transcripts in Eα−/− mice. These results indicate that Eδ func-
tions in DN thymocytes to promote Tcrd gene rearrangement 
and gene expression but not Jα accessibility to the V(D)J re-
combinase. On the other hand, Eα functions in DP thymo-
cytes to promote TCRα gene rearrangement via Jα accessibility 
and controls both Tcrd and Tcra gene expression. However, 
because TCRα chains were still present in Eα−/− mice, it was 
hypothesized that in the absence of Eα, the Eδ enhancer or 
other elements might have a role in promoting rearrangement, 
possibly via the promotion of Jα accessibility and/or expres-
sion of some Vα segments (11). This would account for the 
TCRα chains with limited diversity (mostly Vα2) that were 
expressed in peripheral lymphoid tissue in Eα-defi  cient mice.
In this study, we have tested the hypothesis that a low 
level of Vα to Jα rearrangements is controlled by the Eδ en-
hancer and occurs in DN thymocytes earlier than the bulk of 
Eα-controlled Vα to Jα rearrangements, thus leading to the 
expression of αβTCR in DN cells, which permits some of 
these cells to enter the αβ lineage of DP thymocytes.
RESULTS
Early 𝗂𝗃TCR-expressing DN cells
Analyzing total thymocytes and DN thymocytes from wild-
type (wt) C57BL/6 mice, we fi  nd that  5% express TCRβ 
chains on the cell surface of which  10% are paired with Vα2-
containing TCRα chains (Fig. 1 A). Because a subset of NKT 
cells (14) has the TCRβ+ CD4−CD8− phenotype, NK1.1 
cells were excluded by using NK1.1 antibodies for depletion as 
well as by the analysis of NKT cell–defi  cient CD1−/− animals 
(Fig. 2). The results show that Vα+,TCRβ+ cells belong to a 
distinct, non–NKT cell subset of DN cells. In addition, we 
found TCRβ+ DN T cells in secondary lymphoid organs in 
both wt and CD1- defi  cient animals (Fig. 2).
Figure 1.  V𝗂2-enriched early 𝗂𝗃 T cells in wt and Ptcra−/− mice. 
(A) TCRβ versus Vα2 FACS profi  le in thymi of wt and Ptcra−/− thymo-
cytes. DN (CD4−CD8−) cells were electronically gated after the exclusion 
of CD4+, CD8+, and NK1.1 cells. (B) A CD4 versus CD8 profi  le of Ptcra−/− 
thymi. (C and D) Staining of Ptcra−/− thymocytes (total or CD4−CD8−) 
with TCRβ and Vα2 antibodies. Numbers in quadrants indicate the 
  percentages of cells in that quadrant.JEM VOL. 203, June 12, 2006  1545
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To investigate whether DN αβTCR-expressing cells 
are pre-TCR selected as their DP (CD4+CD8+) or SP 
(CD4+CD8− and CD4−CD8+) counterparts, thymocytes 
from Ptcra−/− mice were analyzed (Fig. 1 B). Although 
Ptcra−/− mice were previously shown to be defi  cient in NKT 
cells (15), we used NK1.1 antibodies in the depletion procedure 
Figure 2.  CD4−CD8− 𝗂𝗃 T cells in the thymus and lymphoid 
  periphery. (A) CD4,CD8 versus NK1.1 staining in the thymus of wt and 
CD1−/− mice (top). TCRβ versus Vα2 analysis of NK1.1− CD4−CD8− 
  thymocytes (bottom). (B and C) Identifi  cation of peripheral CD4−CD8− 
Figure 3.  Phenotype and developmental potential of early 𝗂𝗃 
T cells. (A) Vα2 versus TCRβ staining of Ptcra−/−,Tcrd−/− thymocytes. 
(B) Phenotypic analysis of CD4−CD8− and CD4−CD8− TCRβ+ cells using 
CD44 and CD25 antibodies. (C) Embryonic day 14.5 fetal (Rag-1−/−) thymic 
organ culture of CD4−CD8− TCRβ+ NK1.1− Ptcra−/− cells. Cells were 
  cultured for 7 d and were stained with Vα2, TCRβ, CD4, and CD8 antibodies. 
A CD4 versus CD8 staining of Vα2+ donor cells is also shown (bottom). 
Numbers in quadrants indicate the percentages of cells in that quadrant.
TCRβ+ cells in the spleen and lymph nodes using TCRβ, Vα2, CD4, and 
CD8 antibody labeling. Numbers in quadrants indicate the percentages 
of cells in that quadrant.1546  REGULATION OF EARLY αβTCR EXPRESSION | Aifantis et al.
that yielded DN thymocytes. In Ptcra−/− mice,  6–7% of DN 
thymocytes express TCRβ chains on the cell surface, and, in 
this particular experiment, 40–50% of DN cells with TCRβ 
proteins coexpressed Vα2,TCRα chains (Fig. 1 C). In several 
experiments, the proportion of Vα2+ cells among TCRβ+ 
DN cells in Ptcra−/− mice was variable and ranged between 10 
and 50% (Fig. 4; see Fig. 7).
Of interest was the observation that Vα2 is not only con-
tained in αβ but also in γδTCRs in DN thymocytes from 
Ptcra−/− mice (Fig. 1 C), a notion consistent with recent 
fi  ndings that Vα2 gene segments can join to both Jα and 
DδJδ sequences (16). To exclude that the existence of 
TCRβ+,Vα2+ DN cells is the result of Vα2 segment pairing 
with TCRδ diversity joining elements (16), a similar analysis 
was conducted in Ptcra−/−,Tcrd−/− double-defi  cient  mice. 
About 7% of CD4−CD8− cells were found to express TCRβ 
proteins on the cell surface, and  25% of the TCRβ chains 
were paired with Vα2-containing TCRα chains, suggesting 
that these TCRβ-expressing cells are bona fi  de αβ T cells 
that do not require pre-TCR selection (Fig. 3 A).
Further phenotypic analysis of the TCRαβ+ thymocytes 
showed that almost all “early” TCRβ-expressing CD4−CD8− 
cells are CD25 negative and, thus, belong to the DN4 
(CD25−CD44−) subset (Fig. 3 B). The developmental 
  potential of early αβTCR-expressing DN cells was then 
  addressed by culturing purifi  ed LY5.2+ CD4−CD8− NK1.1− 
Figure 4.  E𝗂 controls late but not early development of 𝗂𝗃 
T cells. (A) Absolute cell numbers of Ptcra−/− and Ptcra−/−,Eα−/− litter-
mates. Error bars represent SD. (B) CD4 versus CD8 profiles of litter-
mates belonging to all indicated genotypes. (C and D) Vα2 versus TCRβ 
antibody labeling in total DN thymocytes (C) and spleen cells (D). Num-
bers in quadrants indicate the percentages of cells in that quadrant.JEM VOL. 203, June 12, 2006  1547
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γδTCRβ+  Ptcra−/− thymocytes together with embryonic 
thymi from LY5.1+ in Rag1−/− donors in fetal thymic organ 
cultures. After 7 d of culture,  40% of the donor-derived 
cells have up-regulated the expression of CD4,CD8 corecep-
tors. Moreover, >90% of the cultured thymocytes retain the 
surface expression of TCRβ, and  20% of them are Vα2+ 
(Fig. 3 C). Not all cells up-regulate CD4 and CD8, however, 
and a substantial fraction of cells expressing high levels of 
Vα2-containing αβTCRs remain CD4−CD8−. It is likely 
that these αβTCR-expressing DN cells normally exit the 
thymus because CD4−CD8− αβTCR+ cells can be detected 
in the lymph nodes and spleen of adult mice (Fig. 2), and it 
was shown in TCRαβ transgenic mice that DN cells with 
the transgenic TCR can accumulate in peripheral lymphoid 
tissue (6). Thus, TCRαβ-expressing DN cells can give rise to 
both immature DP and mature SP (CD4/8) T cells as well as 
DN αβ T cells that do not enter the DP αβ lineage (17).
The E𝗂 enhancer controls late but not early development 
of 𝗂𝗃 T cells in Ptcra−/− mice
To address the role of the described TCR enhancers on early 
TCRα expression, we generated Ptcra−/− mice with a tar-
geted deletion of the Eα locus (Ptcra−/−,Eα−/−). Ptcra−/−,
Eα−/− and Ptcra−/−,Eα+/+ littermate mice contain similar 
numbers of thymocytes (Fig. 4 A). However, there is a clear 
reduction of CD4+CD8− SP thymocytes in the Ptcra−/−, 
Eα−/− mice because of limited TCRα diversity and/or ex-
pression levels (Fig. 4 B). This is supported by the staining of 
either all thymocytes or only DN thymocytes with a combi-
nation of TCRβ and Va2 antibodies: although total thymo-
cytes from Ptcra−/− single-defi  cient mice contain <10% 
TCRβ+,Vα2+ cells, among TCRβ+ cells, this proportion is 
much higher (>30%) in Ptcra−/−,Eα−/− double-defi  cient 
mice. In DN thymocytes from Ptcra−/−,Eα+/+ mice, 
TCRβ+,Vα2+ cells represent 10% of all TCRβ+ cells, 
whereas in Ptcra−/−,Eα−/− mice, TCRβ+,Vα2+ cells repre-
sent 50%. These data indicate that Eα is not required for the 
early rearrangement and expression of Tcra genes (Fig. 4 C). 
The data show that normally Eα predominantly contributes 
to the rearrangement and expression of TCRα V gene seg-
ments other than Vα2 gene segments. Consistent with this 
notion, the spleen of Ptcra−/−,Eα−/− mice contains almost 
exclusively Vα2+,TCRβ+ cells, whereas only  10% of 
Vα2+,TCRβ+ cells among TCRβ+ cells are found in the 
spleen of Ptcra−/−,Eα+/+ mice (Fig. 4 D). These observations 
are in line with earlier observations in Eα−/− mice (11) show-
ing that TCRβ+ cells in the spleen of Eα−/− mice express 
  almost exclusively Vα2 (Fig. 4 D).
DN cells but not mature T cells in E𝗂−/−-defi  cient mice 
express V𝗂2-negative Tcra genes
The data in Fig. 4 suggest that DN cells in Eα−/− mice can 
express Vα genes other than Vα2 and that the Vα2 domi-
nance in the periphery of Eα−/− mice is established at a later 
developmental stage. This issue was addressed in more detail 
by analyzing the expression of TCR Vα2 genes and other 
TCRα V genes (Vα3, Vα8, and Vα11) in Ptcra−/− and 
Ptcra−/−,Eα−/− mice at various stages of development. As 
shown in Fig. 5 B, NKT cell–depleted CD4− and CD8− 
(DN) cells from both Ptcra−/− and Ptcra−/−,Eα−/− mice do 
Figure 5.  Immature but not mature T cells from E𝗂−/− mice express 
diverse TCR𝗂 chains. (A) Staining of thymocytes from Ptcra−/−,Eα+/+ 
and Ptcra−/−,Eα−/− mice with CD4 and CD8 (top), and staining of 
CD4+CD8+ TCRβ+ cells with Vα3 + Vα8 + Vα11 antibodies versus Vα2 
antibodies (middle). Bottom panel shows isotype controls for the staining 
in the middle panel. (B) Staining of NK1.1− CD4−CD8− TCRβ thymocytes 
from Ptcra−/−,Eα+/+ and Ptcra−/−,Eα−/− mice with Vα3 + Vα8 + Vα11 
antibodies versus Vα2 antibodies (top) and with isotype controls (bottom). 
Numbers in quadrants indicate the percentages of cells in that quadrant.1548  REGULATION OF EARLY αβTCR EXPRESSION | Aifantis et al.
express Vα genes that stain with a cocktail of Vα3, 8, and 11 
antibodies. Although the proportion of cells stained with the 
cocktail versus Vα2-positive cells remains about the same in 
CD4+CD8+ cells of Ptcra−/− mice, it drastically decreases in 
DP cells of Eα−/− mice such that the vast majority of cells 
expresses Vα2 (Fig. 5 A). This trend is also evident in periph-
eral T cells from Eα−/− but not wt mice in which virtually all 
TCRβ+ cells express Vα2 (Fig. 4 D). Thus, these data indi-
cate that the predominance of Vα2 expression in peripheral 
T cells of Eα−/− mice is not caused by the fact that the Eδ 
enhancer only allows for Vα2 rearrangement at the DN stage 
of T cell development. Instead, this is likely the result of the 
fact that Vα2 gene segments are able to sustain a suffi   ciently 
high expression of Tcra genes in the absence of the Eα en-
hancer such that only Vα2-positive αβ T cells can be posi-
tively selected and maintained in peripheral lymphoid tissue.
E𝗅 controls V𝗂 expression in DN cells
Because the analysis of Ptcra−/−,Eα−/− mice has shown that Eα 
is not an enhancer element required for early TCRαβ expres-
sion and pre-TCR–independent T cell development (8, 11), we 
have focused our attention on the Eδ enhancer by generating 
and studying animals that lack both Ptcra as well as the Eδ en-
hancer element (Ptcra−/−,Eδ−/− mice). When compared with 
Ptcra−/−,Eδ+ thymi, it was noted that Ptcra−/−,Eδ−/− thymi 
contain much-reduced numbers of thymocytes (Fig. 6 A) that 
are severely defi  cient in DP and SP cells (Fig. 6 B). Also, the 
number of γδTCR-expressing cells is reduced even though some
γδ T cells are still present. Within the DN compartment, there 
is a more complete block at the DN3 stage of development in 
Ptcra−/−,Eδ−/− versus Ptcra−/−,Eδ+ mice (Fig. 6, C and D).
Ablation of Eδ in Ptrcra−/− mice has a profound eff  ect on 
the percentage and absolute number of DN αβTCRs as well as 
of Vα2-expressing cells, as TCRβ+,Vα2+ thymocytes are vir-
tually absent (<0.25%; Fig. 7, A and B). However, there was a 
small number of TCRβ-expressing cells among total thymo-
cytes in some of the Ptcra−/−,Eδ−/− mice (Fig. 7), suggesting 
some remaining level of TCRα rearrangement in the Ptcra−/−, 
Eδ−/− thymi (perhaps mediated by the Eα enhancer in cells) 
that was “rescued” by the expression of γδTCR at the DN 
  developmental stage (8).
Thus, in the absence of Ptcra, the Eδ enhancer has a cru-
cial role in the early assembly of TCRα chains as well as 
TCRδ chains in DN3 and/or earlier stages of T cell develop-
ment (i.e., TCR chains that are required for the formation of 
γδ and αβTCR in the absence of pre-TCR). The αβTCRs 
(and γδTCRs) can rescue some developmental progression 
beyond the DN3 stage in Ptcra-defi  cient mice, which appro-
priately explains the incomplete developmental block in 
  Ptcra−/− versus CD3−/− or Tcrb−/− × Tcrd−/− mice (i.e., mice 
that cannot assemble any TCR on the cell surface).
DISCUSSION
The results obtained in mice with a combined defi  ciency of 
the pre-TCRα chain plus the Eα or Eδ enhancer provide an 
explanation for the observation that development of DN 
Figure 6.  E𝗅 is essential for pre-TCR–independent T cell develop-
ment. (A) Absolute cell numbers of Ptcra−/− and Ptcra−/−,Eδ−/− litter-
mates. 4–8-wk-old mice were analyzed. Error bars represent SD. (B and C) 
CD4 versus CD8 (B) and TCRβ versus TCRγδ (C) profi  les of littermate thymi. 
(D) Analysis of the DN compartment using CD25 and CD44 antibodies. 
Numbers in quadrants indicate the percentages of cells in that quadrant.JEM VOL. 203, June 12, 2006  1549
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thymocytes into αβ lineage DP cells in Ptcra−/−,Tcrd−/− 
double-defi  cient mice can be rescued by αβTCR. The data 
indicate that Eδ can promote early Vα to Jα rearrangements, 
which results in the expression of an αβTCR on the surface 
of DN4 thymocytes. The early expression of an αβTCR was 
previously considered to represent a transgenic artifact caused 
by the too early expression of TCRα chains in TCR trans-
genic mice (18), but, as shown here, it also occurs under 
physiological conditions. Our experiments and earlier exper-
iments in TCRα transgenic mice show that some but not all 
of the αβTCR CD4−CD8− cells can become CD4+CD8+ 
cells (8, 18). This developmental pathway may make only a 
limited contribution to the generation of DP αβ lineage cells 
in pre-TCR–competent mice not only because of the paucity 
of TCRα chains in DN cells of normal mice but also because 
TCRα is a bad “surrogate” for pre-TCRα. Indeed, we found 
that under competitive conditions, pre-TCR is far more ef-
fective in the generation of DP cells than αβTCR (19).
The fate of the DN cells that express αβTCR on the cell 
surface and do not become DP thymocytes needs to be further 
evaluated. These cells apparently can leave the thymus because 
they can be detected in the spleen and lymph nodes of normal 
(Fig. 2) as well as in exaggerated numbers in TCRα transgenic 
mice. Such cells were previously shown to acquire functional 
maturity (i.e., respond with proliferation and cytokine produc-
tion to TCR ligation) and to acquire CD8α expression when 
antigenically stimulated. In fact, this unusual subset of T cells 
was analyzed in TCR transgenic mice many years ago, and it 
was concluded that the early expression of an αβTCR could 
mimic signals generated when thymocytes express γδTCR and 
become functionally mature (18, 20). Of interest is that such 
cells can express an autoreactive TCR but are not deleted be-
cause of the lack of coreceptors and can accumulate in second-
ary lymphoid tissue of mice, as shown in various TCR transgenic 
models (21). Some of these cells exhibit an activated phenotype 
and have an as yet undefi  ned role in the immune system.
Recent data have, in fact, shown that the extensive accu-
mulation of CD8αα cells in the gut of TCR transgenic mice 
(22) to a large extent depends on the premature expression of 
the transgenic TCR in DN cells because “on time” expres-
sion of the same Tcra transgene does not result in the strong 
accumulation of CD8αα cells in the gut (23). Another possi-
bility is that thymic DN αβTCR+ cells represent precursors 
of some peripheral regulatory T cells. Perhaps these cells are 
akin to both mouse and human αβTCR+ CD3+ NK.1.1− 
CD4−CD8− DN Regulatory T cells that can suppress anti-
gen-specifi   c immune responses mediated by CD8+ and 
CD4+ T cells through a process that requires cell to cell con-
tact and Fas–FasL interactions (24). In this regard, it is impor-
tant to point out that the αβTCR+ DN studied here are 
diff  erent from NK1.1+ DN T cells and from αβTCR+ DN 
cells studied by others who concluded that all TCRβ+ DN 
cells were derived from DP precursors (25); either this gen-
eralization is wrong or the fate mapping approach used by the 
authors is not valid. However, it is clear that the TCRβ+ DN 
cells in Ptcrd−/−, Tcrd−/− mice are involved in the rescue of 
development rather than being derived from DP cells (8).
The results shown in this study also provide an adequate 
explanation for earlier observations in Eα-defi  cient mice that 
exhibited a TCRα repertoire limited to TCRα,Vα2 chains. 
In this context, on Eα-deleted alleles, other cis-acting ele-
ments such as Eδ and/or Vα2 promoters were hypothesized 
to promote either only Vα2 to Jα rearrangements or Vα to Jα 
rearrangements. These rearrangements involve a diverse array 
of Vα segments with assembled Vα2Jα complexes expressed 
in a much higher proportion in the absence of Eα. Our results 
indicate that in DN cells, Eδ can direct a low level of Vα to 
Jα rearrangements, possibly via promoting Jα accessibility that 
results in the expression of a variety of diff  erent Vα gene seg-
ments. The early expressed αβTCRs allow the development 
of some DP thymocytes with TCRs containing mostly 
Vα2+,TCRα chains. In the absence of Eα, only early VαJ 
rearrangements with a high proportion of Vα2 would con-
tinue to be expressed in DP thymocytes and mature T cells, 
perhaps because their promoters do not require Eα activity 
to drive gene expression. This pathway of diff  erentiation ob-
served in Eα-defi  cient mice might be invisible in wt mice be-
cause of continual Tcra rearrangement in DP thymocytes that 
will swamp out the Eδ-initiated Vα rearrangements and, 
thereby, lead to a much more diverse αβTCR repertoire.
MATERIALS AND METHODS
Mice. Mice were kept in the sterile facilities of The University of Chicago, 
Dana-Farber Cancer Institute, and Children’s Hospital. Animal protocols 
Figure 7.  Absence of V𝗂2-expressing cells in the thymi of 
Ptcra−/−,E𝗅−/− mice. TCRβ versus Vα2 staining of either total thymo-
cytes (A) or CD4−CD8− cells (B) of littermate mice analyzed at 4 wk 
of age. Numbers in quadrants indicate the percentages of cells in 
that quadrant.1550  REGULATION OF EARLY αβTCR EXPRESSION | Aifantis et al.
were approved by the Institutional Animal and Use Committees of these 
  institutes. C57BL/6, Rag1−/−, and Tcrd−/− mice (also on the C57BL/6 
background) were purchased from Jackson ImmunoResearch Laboratories. 
C57BL/6 CD1−/− were provided by A. Bendelac (The University of Chi-
cago, Chicago, IL). Eα−/− and Eδ−/− mice were generated in the laboratory 
of Frederick W. Alt (10, 11). Ptcra−/− mice were described previously (7).
Flow cytometric analysis and cell sorting. Anti-CD4 (L3T4), CD8 
(53–6.7), CD25 (3C7), CD44 (IM7), NK1.1 (PK136), TCRß (H57-597), 
γδTCR (GL3), Va2 (B20.1), Va11 (RR8-1), and Va3 (RR3-16) mAbs 
were purchased from BD Biosciences. The Va8 (CTVA8) antibody was pur-
chased from CALTAG. These mAbs were directly coupled to FITC, PE, 
Cy-crome, APC, or biotin. Surface marker expression on thymocytes and 
peripheral T cells was visualized using a FACScalibur (Becton Dickinson) 
and analyzed with FlowJo (Tree Star) and CellQuest software (Beckton 
Dickinson). Cell sorting was performed using Mo-Flo (DakoCytomation) 
and FACS-Aria (Becton Dickinson) sorters.
Fetal thymic organ culture. Thymi were cultured as described previously 
(26). In brief, (LY5.2+) TCRβ+ CD4−CD8− NK1.1− cells were FACS pu-
rifi  ed from thymi of Ptcra−/− animals. Lineage-negative (CD3, CD8, Mac-1, 
NK1.1, Gr-1, Ter-119, and CD19) bone marrow progenitors were also used 
as a reconstitution control. Isolated embryonic day 14.5 thymi from Rag1 
mice (expressing LY5.1) were initially incubated in Terasaki plates (Nunc), 
subsequently applied on Transwell (Nunc) porous fi  lters, and incubated in 
Iscove’s modifi  ed Dulbecco’s medium supplemented with 10% fetal calf 
  serum (Sigma-Aldrich) plus penicillin, streptomycin, and mercapto-ethanol. 
Cultures were maintained at 37°C for 7 d, after which LY5.2+ cells were 
stained and analyzed by FACS analysis.
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